American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

@article{Saslow2002AmericanCS,
  title={American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer},
  author={Debbie Saslow and Carolyn D Runowicz and Diane H. Solomon and Anna‐Barbara Moscicki and Robert A. Smith and HarmonJ. Eyre and Carmel J. Cohen},
  journal={CA: A Cancer Journal for Clinicians},
  year={2002},
  volume={52}
}
An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid‐based cytology and HPV DNA testing. 
American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors
TLDR
Recommendations on the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues, and implications for screening are discussed. Expand
Cervical cancer screening in the early post vaccine era.
  • A. Waxman
  • Medicine
  • Obstetrics and gynecology clinics of North America
  • 2008
TLDR
The author reviews the current recommendations for cervical cancer screening by the American Cancer Society and the American College of Obstetricians and Gynecologists and the evidence supporting them, reviews the relative efficacy of liquid-based cytology versus the conventional Pap smear, and discusses the role of HPV DNA testing in primary screening. Expand
Update on cervical cancer screening
TLDR
The authors review the 2001 revision of the Bethesda System and the new evidence-based protocols for managing patients with abnormal Pap smears and offer more effective tools for classification of disease severity and appropriate treatment options. Expand
American Cancer Society Guidelines for the Early Detection of Cancer, 2005
TLDR
The current guidelines for early cancer detection are summarized, recent evidence and policy changes that have implications for cancer screening are discussed, and the most recent data pertaining to participation rates in cancer screening by age, gender, and insurance status from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System are provided. Expand
Primary Screening for Cervical Cancer: Incorporating New Guidelines and Technologies into Clinical Practice
TLDR
The aim of this article is to provide an evidence-based approach to incorporation of the new cervical cancer screening guidelines into clinical practice by reviewing the goals of screening, epidemiology of human papillomavirus and cervical cancer, costs of overscreening, and rationale for the specific recommendations. Expand
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
TLDR
The guidelines for early cancer detection are summarized, recent evidence and policy changes that have implications for cancer screening are discussed, and an update of the most recent data pertaining to participation rates in cancer screening by age, sex, and insurance status from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System is provided. Expand
American Cancer Society Guidelines for the Early Detection of Cancer, 2004
TLDR
Each January, the American Cancer Society publishes a summary of its recommendations for early cancer detection, including updates, emerging issues that are relevant to screening for cancer, or both, which are compared with recent ACS updates. Expand
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
TLDR
The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, and screening strategies for women vaccinated against HPV16 and HPV18 infections. Expand
Cervical cancer screening clinical practice guidelines in oncology.
Although primary prevention of human papillomavirus (HPV) infections that are causally associated with invasive cervical cancer may be within our grasp, it is unlikely that these approaches willExpand
Cervical cancer screening: Less testing, smarter testing
TLDR
Recommendations for cervical cancer screening that integrates testing for human papillomavirus infection with the Papanicolaou (Pap) test are reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 115 REFERENCES
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
TLDR
Positive combined test results should provide added reassurance for lengthening the screening interval among low-risk women, whereas positive results identify a relatively small subgroup that requires more frequent surveillance. Expand
Cervical cancer screening in Japan. A case-control study.
TLDR
This case-control study statistically showed the usefulness of screening for cervical cancer in Japan by proving the effectiveness of mass screening with the cervical cytologic smear. Expand
Cervical Cancer Screening Among Low‐Income Women: Results of a National Screening Program, 1991–1995
TLDR
Observed results emphasize the duality of cervical neoplasia—CIN in younger women and invasive cancer in older women, pointing to the importance of reaching both younger and older women for cervical cancer screening. Expand
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings.
TLDR
HPV DNA testing has a sensitivity equivalent to, or better than, that of cytology, and should be considered for primary cervical cancer screening in low-resource settings. Expand
Determinants of Cancer Screening Frequency: The Example of Screening for Cervical Cancer
  • P. Frame, J. Frame
  • Medicine
  • The Journal of the American Board of Family Medicine
  • 1998
TLDR
Rate of disease progression and sensitivity of the screening test are the proper determinants of cancer screening frequency, however, the optimal screening interval for a particular cancer must be determined by clinical trials. Expand
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
TLDR
In this study population, a cut point of 1.0 pg/mL using the second generation assay permitted sensitive detection of cervical high-grade lesions and cancer, yielding an apparently optimal trade-off between high sensitivity and reasonable specificity for this test. Expand
Human papillomavirus testing for primary screening of cervical cancer precursors.
  • S. Ratnam, E. Franco, A. Ferenczy
  • Medicine
  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2000
TLDR
It is concluded that HPV testing in conjunction with cytology improved the screening efficacy of cytology alone and may allow for a more effective and safe primary screening program with increased screening intervals. Expand
Rationale for stopping cervical screening in women over 50.
TLDR
All women over 50 with an adequate history of negative results on smear testing every three years may be safely discharged from further screening if these findings are confirmed in other populations. Expand
Risk factors for rapid-onset cervical cancer.
TLDR
Results from this study suggest that the risk factors associated with the development of rapid-onset cervical cancer are similar to those for normal-ONSet disease. Expand
Frequency of Cervical Smear Abnormalities Within 3 Years of Normal Cytology
TLDR
Within 3 years after normal cytology results, cervical smears interpreted as high-grade SIL or worse are uncommon, and the incidence rate is unrelated to the time since last normal smear. Expand
...
1
2
3
4
5
...